I now have comprehensive information from Bailey & Love's (28th Ed) and Scott-Brown's to give a thorough, well-organized answer. Let me compile this.
Carcinoma of the Oesophagus - Treatment by Location
(Based on Bailey and Love's Short Practice of Surgery, 28th Edition, and Scott-Brown's Otorhinolaryngology Head & Neck Surgery)
General Principles Before Location-Specific Treatment
The choice of treatment depends on:
- Tumour location (cervical / upper third, middle third, lower third / OGJ)
- Tumour stage (T and N stage)
- Histology (squamous cell carcinoma vs. adenocarcinoma)
- Patient fitness (cardiorespiratory reserve, nutritional status)
The choice of surgical approach "depends mainly on: (i) the location of the tumour, (ii) the intended extent of lymphadenectomy, and (iii) the reconstructive technique."
Upper One Third (Cervical Oesophagus)
Preferred treatment: Definitive chemoradiotherapy (larynx-preserving)
This is the key principle for upper-third / cervical oesophageal cancers:
"Definitive chemoradiotherapy has become the preferred alternative treatment to preserve the larynx. Surgery is therefore mostly reserved for salvage, when there is an incomplete response or for recurrent disease."
Surgical approach (when surgery is needed):
- Pharyngo-laryngo-oesophagectomy (PLO): removes the pharynx, larynx and oesophagus en bloc; a gastric pull-up is used to anastomose with the neo-pharynx.
- If cervical oesophageal involvement is limited: pharyngo-laryngo-cervical oesophagectomy (without total oesophageal resection). The resultant gap is bridged using:
- A free jejunal graft, or
- Various musculocutaneous flaps
- Intraepithelial carcinomas of the upper oesophagus can also be considered for pharyngolaryngo-oesophagectomy with radical neck dissection and a transhiatal oesophageal resection (Scott-Brown's).
Key point: Surgery is radical and morbid (total laryngectomy is inevitable), so non-surgical definitive chemoradiotherapy is the standard first-line curative approach for resectable upper-third squamous cell carcinoma.
Middle One Third (Mid-thoracic Oesophagus)
Preferred treatment: Neoadjuvant chemoradiotherapy (or perioperative chemotherapy) followed by surgery
Surgical approach:
- McKeown (Three-stage / Three-phase) Oesophagectomy - the preferred operation for mid-thoracic cancers:
- Right posterolateral thoracotomy to mobilise the thoracic oesophagus and perform mediastinal lymphadenectomy
- Abdominal incision (laparotomy) for gastric mobilisation
- Neck incision for cervical anastomosis (oesophagogastrostomy in the neck)
- A supra-azygous dissection is performed for middle-third cancers or when staging shows nodes above this level.
- A routine three-phase procedure with neck dissection "is required when the oesophageal lesion is in the upper third or upper part of the middle third of the oesophagus."
Alternative surgical approach:
- Lewis-Tanner (Ivor Lewis) procedure - a two-phase oesophagectomy: laparotomy for gastric mobilisation, followed by right posterolateral thoracotomy with intrathoracic anastomosis. This approach can be used for middle-third tumours though the anastomosis is in the chest rather than the neck.
Definitive chemoradiotherapy: An alternative for squamous cell carcinoma (total disease length not exceeding 10 cm) especially if the patient is unfit for surgery.
Lower One Third (Lower Thoracic Oesophagus and Oesophagogastric Junction)
Preferred treatment: Neoadjuvant chemotherapy (or chemoradiotherapy) followed by surgery
"Two-stage oesophagectomy with a radical lymphadenectomy has been shown to improve outcomes for lower-third adenocarcinoma."
Surgical approach:
-
Lewis-Tanner (Ivor Lewis) Procedure - the standard operation for lower-third cancers:
- Laparotomy - gastric mobilisation, tubularisation, preservation of right gastroepiploic and right gastric vessels, pyloroplasty/pyloromyotomy, feeding jejunostomy insertion
- Right posterolateral thoracotomy (4th or 5th intercostal space) - thoracic oesophageal mobilisation, en-bloc resection with thoracic duct and mediastinal lymph nodes, intrathoracic anastomosis
-
Left Thoracoabdominal incision (Sweet oesophagectomy): A single left posterolateral incision through the 5th-6th intercostal space accessing both the left chest and abdomen; diaphragm opened for gastroplasty. Note: this does not afford optimal access for formal abdominal or complete mediastinal lymphadenectomy.
-
Transhiatal oesophagectomy: Cervical + abdominal approach; oesophagus mobilised bluntly without thoracotomy; gastric conduit delivered to neck for cervical anastomosis. Suitable for lower-third tumours, though it does not allow adequate mediastinal nodal dissection.
For OGJ (Siewert I/II) cancers:
- Above approaches apply with the addition of extended total radical gastrectomy (whole stomach + lower oesophagus resected, intestinal continuity via Roux-en-Y jejunal loop)
- In selected patients with early disease: proximal gastrectomy
Minimally Invasive Approaches (All Locations)
Traditional open procedures are increasingly replaced by:
- VATS (video-assisted thoracoscopy) + laparoscopy, or
- Robotic techniques
Both thoracic and abdominal phases can be minimally invasive, or one phase can be open (hybrid). The anastomosis can be fashioned in the chest or the neck.
Staging-Based Treatment Summary
| Stage | Treatment |
|---|
| T1a (mucosal only) | Endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD) |
| T1b, T2, N0 | Surgery alone (oesophagectomy) |
| ≥T3 or N+ | Multimodality treatment: neoadjuvant chemoradiotherapy/chemotherapy + surgery |
| T4b or M1 (metastatic) | Palliative - stenting, palliative chemotherapy, radiotherapy/brachytherapy |
Special Note on Histology and Radiotherapy
- Squamous cell carcinoma (predominates in upper and middle third): More radiosensitive; definitive chemoradiotherapy is a recognised curative alternative, especially in the upper third and for patients unfit for surgery. Salvage oesophagectomy remains an option after chemoradiotherapy failure.
- Adenocarcinoma (predominates in lower third and OGJ): Less responsive to radiotherapy alone; perioperative chemotherapy (FLOT/MAGIC protocol) or neoadjuvant chemoradiotherapy (CROSS protocol) before surgery is the standard.
Palliation
- Self-expanding metallic stents (SEMS): First-line for dysphagia palliation. Note: stents carry risk of airway compression/tracheal erosion when placed in the mid/upper oesophagus.
- Chemotherapy, radiotherapy, brachytherapy
- Laser, dilatation, photodynamic therapy
- Immunotherapy has promise in selected patients.
Sources: Bailey and Love's Short Practice of Surgery, 28th Edition, pp. 1157-1168; Scott-Brown's Otorhinolaryngology Head & Neck Surgery, pp. 879-882